Aflac/$AFL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aflac
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
Ticker
$AFL
Sector
Primary listing
NYSE
Industry
Insurance
Headquarters
Employees
12,694
ISIN
US0010551028
Website
Aflac Metrics
BasicAdvanced
$55B
15.80
$6.44
0.83
$2.16
2.28%
Price and volume
Market cap
$55B
Beta
0.83
52-week high
$114.45
52-week low
$92.44
Average daily volume
2.6M
Dividend rate
$2.16
Financial strength
Current ratio
8.352
Quick ratio
7.515
Long term debt to equity
29.114
Total debt to equity
29.429
Dividend payout ratio (TTM)
31.03%
Interest coverage (TTM)
22.96%
Profitability
EBITDA (TTM)
4,632.25
Gross margin (TTM)
45.41%
Net profit margin (TTM)
21.27%
Operating margin (TTM)
27.19%
Effective tax rate (TTM)
18.19%
Revenue per employee (TTM)
$1,330,000
Management effectiveness
Return on assets (TTM)
2.34%
Return on equity (TTM)
14.41%
Valuation
Price to earnings (TTM)
15.802
Price to revenue (TTM)
3.346
Price to book
2.1
Price to tangible book (TTM)
2.12
Price to free cash flow (TTM)
23.094
Free cash flow yield (TTM)
4.33%
Free cash flow per share (TTM)
440.94%
Dividend yield (TTM)
2.12%
Forward dividend yield
2.28%
Growth
Revenue change (TTM)
-12.66%
Earnings per share change (TTM)
-28.90%
3-year revenue growth (CAGR)
-7.60%
10-year revenue growth (CAGR)
-2.71%
3-year earnings per share growth (CAGR)
1.79%
10-year earnings per share growth (CAGR)
7.23%
3-year dividend per share growth (CAGR)
14.38%
10-year dividend per share growth (CAGR)
10.59%
What the Analysts think about Aflac
Analyst ratings (Buy, Hold, Sell) for Aflac stock.
Bulls say / Bears say
Aflac's U.S. segment experienced a 3.5% year-over-year increase in sales, driven by strong performance in group life, disability, and dental segments. (TipRanks)
The company maintains high persistency rates, with 93.8% in Japan and 79.3% in the U.S., indicating strong customer retention and business stability. (TipRanks)
Aflac's solid financial position, supported by a strong cash balance and substantial cash flow, enables the company to pursue growth initiatives and engage in prudent capital deployment through share repurchases and dividend payments. (Yahoo Finance)
Aflac's fourth-quarter earnings revealed an EPS of $1.56, missing analyst expectations of $1.62, leading to a 4% decline in share price. (Investing.com)
Net earnings per diluted share were significantly impacted by net investment losses, contrasting with gains in the previous year. (TipRanks)
Aflac Japan's net and earned premiums declined by 5% and 1.4%, respectively, due to deferred profit liability and reinsurance impacts. (TipRanks)
Data summarised monthly by Lightyear AI. Last updated on 27 Jun 2025.
Aflac Financial Performance
Revenues and expenses
Aflac Earnings Performance
Company profitability
Aflac News
AllArticlesVideos
INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
GlobeNewsWire·7 days ago
Barrack, Rodos & Bacine Investigating Data Breach at Aflac
GlobeNewsWire·4 weeks ago
US insurance giant Aflac says customers' personal data stolen during cyberattack
TechCrunch·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aflac stock?
Aflac (AFL) has a market cap of $55B as of July 21, 2025.
What is the P/E ratio for Aflac stock?
The price to earnings (P/E) ratio for Aflac (AFL) stock is 15.8 as of July 21, 2025.
Does Aflac stock pay dividends?
Yes, the Aflac (AFL) stock pays dividends to shareholders. As of July 21, 2025, the dividend rate is $2.16 and the yield is 2.28%. Aflac has a payout ratio of 31.03% on a trailing twelve-month basis.
When is the next Aflac dividend payment date?
The next Aflac (AFL) dividend payment date is unconfirmed.
What is the beta indicator for Aflac?
Aflac (AFL) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.